Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of Bone Marrow Erythropoiesis on Newly Diagnosed Plasma Cell Myeloma: A Single Institutional Analyses

Daniel E Ezekwudo, MD, Rohit Singh, MD, Bolanle Gbadamosi, MD, Mark Micale, PhD, Ishmael Jaiyesimi, DO, MS, Marc Smith, MD

Blood (2018) 132 (Supplement 1): 5579.

https://doi.org/10.1182/blood-2018-99-116619

Published: 2018

Journal Articles

The Clinical Characteristics, Genetic Alterations and Prognostic Significance of Acute Myeloid Leukemia (AML) with Trisomy 8

Bolanle Gbadamosi, MD, Daniel E Ezekwudo, MD PhD, Foluso Ogunleye, MD, Sanjog Bastola, MD, Mary Coffey, PhD, Zhou Yu, MD PhD, Hong Ye, PhD, Michael Stender, MD, Dana Zakalik, MD, Mark Micale, PhD, Ishmael Jaiyesimi, DO, MS

Blood (2017) 130 (Supplement 1): 5101.

https://doi.org/10.1182/blood.V130.Suppl_1.5101.5101

Published: 2017

Journal Articles

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

Foluso Nelson Ogunleye, MD, Mohammed Ibrahim, MD, Leann Michelle Blankenship, MD, Siddhartha Yadav, MD, Tolulope Ifabiyi, Vonda Douglas, MD, Mark Micale, PhD, Elisa Quiroz, MD, Susanna S Gaikazian, MD, Michael Stender, MD, Marianne Terese Huben, DO, Joseph Anderson, MD, Ishmael Jaiyesimi, DO

Blood (2016) 128 (22): 5580.

https://doi.org/10.1182/blood.V128.22.5580.5580

Published: 2016

Journal Articles

Venous Thrombotic Events (VTEs) in Acute Myeloid Leukemia (AML) Patients During Induction Therapy (IT): Identifying Risk Factors, and Safety of Using Anticoagulation Therapy

Alaa Muslimani, MD, Aya Rifai, MD, Mohammad Muhsin Chisti, MD, Ayham Ashkar, MD, Kinda Muslemani, MD, Jeffery Margolis, MD, Laura Nadeau, MD, Hong Ye, MS, Mark Micale, PhD, James Huang, MD, Ishmael Jaiyesimi, DO

Blood (2011) 118 (21): 3148.

https://doi.org/10.1182/blood.V118.21.3148.3148

Published: 2011

Journal Articles

Pulmonary Infiltrates (PI) in Acute Myeloid Leukemia (AML) During Induction Treatment (IT). How Much Do We Know?

Alaa Muslimani, MD, Mohammad Muhsin Chisti, MD, Jeffery Margolis, MD, Laura Nadeau, MD, Hong Ye, MS, Mark Micale, PhD, James Huang, MD, Ishmael Jaiyesimi, DO

Blood (2011) 118 (21): 2087.

https://doi.org/10.1182/blood.V118.21.2087.2087

Published: 2011

NARROW

Prognostic Impact of Bone Marrow Erythropoiesis on Newly Diagnosed Plasma Cell Myeloma: A Single Institutional Analyses

The Clinical Characteristics, Genetic Alterations and Prognostic Significance of Acute Myeloid Leukemia (AML) with Trisomy 8

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

Venous Thrombotic Events (VTEs) in Acute Myeloid Leukemia (AML) Patients During Induction Therapy (IT): Identifying Risk Factors, and Safety of Using Anticoagulation Therapy

Pulmonary Infiltrates (PI) in Acute Myeloid Leukemia (AML) During Induction Treatment (IT). How Much Do We Know?

Email alerts

ASH Publications

American Society of Hematology

Prognostic Impact of Bone Marrow Erythropoiesis on Newly Diagnosed Plasma Cell Myeloma: A Single Institutional Analyses

The Clinical Characteristics, Genetic Alterations and Prognostic Significance of Acute Myeloid Leukemia (AML) with Trisomy 8

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

Venous Thrombotic Events (VTEs) in Acute Myeloid Leukemia (AML) Patients During Induction Therapy (IT): Identifying Risk Factors, and Safety of Using Anticoagulation Therapy

Pulmonary Infiltrates (PI) in Acute Myeloid Leukemia (AML) During Induction Treatment (IT). How Much Do We Know?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only